Effect of adjunctive vaginal progesterone after McDonald cerclage on the rate of second-trimester abortion in singleton pregnancy: a randomized controlled trial
- PMID: 32246762
- DOI: 10.1002/ijgo.13148
Effect of adjunctive vaginal progesterone after McDonald cerclage on the rate of second-trimester abortion in singleton pregnancy: a randomized controlled trial
Retraction in
-
Retraction: Effect of adjunctive vaginal progesterone after McDonald cerclage on the rate of second-trimester abortion in singleton pregnancy: A randomized controlled trial.Int J Gynaecol Obstet. 2024 Feb;164(2):806. doi: 10.1002/ijgo.15318. Epub 2023 Dec 18. Int J Gynaecol Obstet. 2024. PMID: 38108640
Abstract
Objective: To evaluate the effect of adjunctive use of vaginal progesterone after McDonald cerclage on the rate of second-trimester abortion in singleton pregnancy.
Methods: A randomized controlled trial at Woman's Health Hospital, Assiut University, Egypt, between April 2017 and March 2019 enrolled women eligible for McDonald cerclage. After cerclage, participants were randomly assigned to receive progesterone (400 mg pessary) once daily until 37 weeks or no progesterone. The primary outcome was rate of abortion before 28 weeks. Secondary outcomes included gestational age at delivery, preterm delivery, mean birthweight, Apgar score, and admission to the neonatal intensive care unit (NICU).
Results: The rate of spontaneous abortion was higher in the no-progesterone group (P=0.016). Mean gestational age and mean birthweight was higher in the progesterone group (P<0.001 and P=0.002, respectively). The frequency of preterm neonates, neonates with Apgar score less than 7, and admission to NICU was higher in the progesterone group than in the no-progesterone group (P=0.005, P=0.008, and P=0.044, respectively).
Conclusion: Adjunctive use of vaginal progesterone after McDonald cerclage was found to decrease the frequency of second-trimester abortion and to improve perinatal outcomes in singleton pregnancy. Clinicaltrials.gov: NCT02846909.
Keywords: Cerclage; Perinatal outcome; Progesterone; Spontaneous abortion.
© 2020 International Federation of Gynecology and Obstetrics.
References
REFERENCES
-
- Linehan LA, Morris AG, Meaney S, O'Donoghue K. Subsequent pregnancy outcomes following second trimester miscarriage-A prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2019;237:198-203.
-
- Westin M, Källén K, Saltvedt S, Almström H, Grunewald C, Valentin L. Miscarriage after a normal scan at 12-14 gestational weeks in women at lowrisk of carrying a fetus with chromosomal anomaly according to nuchal translucency screening. Ultrasound Obstet Gynecol. 2007;30:728-736.
-
- Turocy JM, Rackow BW. Uterine factor in recurrent pregnancy loss. Semin Perinatol. 2019;43:74-79.
-
- Wang HL, Yang Z, Shen Y, Wang QL. Clinical outcome of therapeutic cervical cerclage in short cervix syndrome. Zhonghua Fu Chan KeZaZhi. 2018;53:43-46.
-
- Alfirevic Z, Stampalija T, Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev. 2017;6:CD008991.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous